MedLink Neurology: The Information Resource for Clinical Neurology

Home Contents

MedLink Neurology Home

Your First Place To Look™ for authoritative, in-depth articles covering the full spectrum of neurology

Alerts

FDA approves oral treatment for spinal muscular atrophy

Aug 07, 2020

First drug for spinal muscular atrophy that can be taken orally, providing an important treatment option for patients with this disease.

CDC reports a novel strain of antibiotic-resistant meningitis

Jun 19, 2020

CDC issues new recommendation for treatment of deadly meningitis.

Resource Centers

Behavioral & Cognitive Disorders
Childhood Degenerative & Metabolic Disorders
Developmental Malformations
Epilepsy & Seizures
Headaches & Pain
Infectious Disorders
Miscellaneous Neurology Disorders
Miscellaneous Pediatric Neurology Disorders
Movement Disorders
Neuro-Oncology
Neuro-Ophthalmology & Neuro-Otology
Neuroimmunology
Neuromuscular Disorders
Peripheral Neuropathies
Sleep Disorders
Stroke & Vascular Disorders

Site Overview - Key Features

Articles
1,200 continually-updated authoritative clinical reviews covering the entire spectrum of neurology.
Images and Videos
Nearly 3,000 illustrations, including video clips of neurologic disorders.
CME Information
Earn AMA PRA Category 1™ CME credits for routinely using MedLink Neurology.
Editorial Board
Distinguished Editorial Board and hundreds of expert authors.
External Resources
The world’s largest annotated directory of useful resources for neurologists.
Forum
Interact with your colleagues. Your privacy is protected.
Patient Handouts
Information for patients you can print or email when needed.
News
See what’s being published in the neurology and neuroscience literature.
Learn More

CME Accreditation

MedLink Corporation is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.

MedLink Corporation designates each MedLink Neurology internet point-of-care activity for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. “AMA PRA Category 1 Credit” is a trademark of the American Medical Association.

Learn more and then earn CME credits.

Editorial Board

Editor-In-Chief

Raymond P Roos MD, Editor-in-Chief, is the Marjorie and Robert E Straus Professor of Neurology at the University of Chicago and Associate Chair for Education for the Department of Neurology at University of Chicago Medical Center.

View the complete Editorial Board here.

Selected News

“Rare” brain disorder may not be so rare anymore, trends in Japan reveal

Oct 19, 2020

Scientists show that incidence and mortality of a rare brain disorder in Japan almost doubled from 2005 to 2014.

Investigational ALS drug prolongs patient survival in clinical trial

Oct 16, 2020

An experimental medication that was recently shown to slow the progression of amyotrophic lateral sclerosis has now demonstrated the potential to also prolong patient survival.

View All